Habeo Cell Therapy (ECCS-50) - Plus Therap
ENDURE: A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells (clinicaltrials.gov) - Oct 8, 2020 - P=N/A; N=250; Not yet recruiting; Sponsor: Sanford Health; Initiation date: Sep 2020 ➔ Dec 2020 
Trial initiation date • Immunology • Osteoarthritis • Pain • Rheumatology
http://clinicaltrials.gov/ct2/show/NCT04405297
 
Oct 8, 2020
 
Prev Next